{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:42:35Z","timestamp":1793742155367,"version":"4.6.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejmech.2024.116163","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T12:16:32Z","timestamp":1706184992000},"page":"116163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Discovery of new piperaquine hybrid analogs linked by triazolopyrimidine and pyrazolopyrimidine scaffolds with antiplasmodial and transmission blocking activities"],"prefix":"10.1016","volume":"267","author":[{"given":"Livia M.","family":"Feitosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo Rodrigo F.","family":"Franca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria de Lourdes G.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.C.","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme E.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah El Chamy","family":"Maluf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana O.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Cristina","family":"Nonato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6398-7717","authenticated-orcid":false,"given":"Luiz C.S.","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael V.C.","family":"Guido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nubia","family":"Boechat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116163_bib1","series-title":"World Malaria Report 2022","year":"2022"},{"key":"10.1016\/j.ejmech.2024.116163_bib2","article-title":"Recent developments in antimalarial drug discovery","volume":"88\u201389","author":"Umumararungu","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116163_bib3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijpddr.2021.05.007","article-title":"Plasmodium falciparum resistance to ACTs: emergence, mechanisms, and outlook","volume":"16","author":"Siddiqui","year":"2021","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2024.116163_bib4","first-page":"26","article-title":"Resistance to artemisinin combination therapies (ACTs): do not forget the partner drug","volume":"4","author":"Nsanzabana","year":"2019","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116163_bib5","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","article-title":"Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study","volume":"21","author":"Uwimana","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116163_bib7","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1038\/s41467-023-39914-3","article-title":"Preventing antimalarial drug resistance with triple artemisinin-based combination therapies","volume":"14","author":"Nguyen","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116163_bib8","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1021\/acs.jmedchem.9b00761","article-title":"The development process for discovery and clinical advancement of modern antimalarials","volume":"62","author":"Ashton","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116163_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","article-title":"The past, present and future of anti-malarial medicines","volume":"18","author":"Tse","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2024.116163_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00249-17","article-title":"Are antimalarial hybrid molecules a close reality or a distant dream?","volume":"61","author":"Agarwal","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116163_bib11","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands. An emerging drug discovery paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116163_bib12","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.3390\/molecules17078285","article-title":"New trifluoromethyl triazolopyrimidines as Anti-Plasmodium falciparum agents","volume":"17","author":"Boechat","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116163_bib13","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1016\/j.bmc.2015.06.056","article-title":"Anti-Plasmodium falciparum activity of quinoline-sulfonamide hybrids","volume":"23","author":"Pinheiro","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116163_bib14","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1016\/j.bmc.2016.07.049","article-title":"Design, synthesis and anti-P. falciparum activity of pyrazolopyridine-sulfonamide derivatives","volume":"24","author":"Silva","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116163_bib15","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.bmcl.2016.03.027","article-title":"New pentasubstituted pyrrole hybrid atorvastatin-quinoline derivatives with antiplasmodial activity","volume":"26","author":"Carvalho","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116163_bib16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejmech.2016.09.073","article-title":"Evaluation of 7-arylaminopyrazolo[1,5-a]pyrimidines as anti-Plasmodium falciparum, antimalarial, and Pf-dihydroorotate dehydrogenase inhibitors","volume":"126","author":"Azeredo","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116163_bib17","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.3390\/molecules24224095","article-title":"The development of novel compounds against malaria: quinolines, triazolpyridines, pyrazolopyridines and pyrazolopyrimidines","volume":"24","author":"Pinheiro","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116163_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115832","article-title":"Antimalarial and anti-inflammatory activities of new chloroquine and primaquine hybrids: targeting the blockade of malaria parasite transmission","volume":"28","author":"Boechat","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116163_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112941","article-title":"Comparative study between the anti-P. falciparum activity of triazolopyrimidine, pyrazolopyrimidine and quinoline derivatives and the identification of new PfDHODH inhibitors","volume":"209","author":"Silveira","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116163_bib20","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.bmc.2019.01.044","article-title":"New hybrid trifluoromethylquinolines as antiplasmodium agents","volume":"27","author":"Silva","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116163_bib21","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3390\/ph16060782","article-title":"Antiplasmodial, trypanocidal, and genotoxicity in vitro assessment of new hybrid \u03b1,\u03b1-Difluorophenylacetamide-statin derivatives","volume":"16","author":"Araujo-Lima","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2024.116163_bib22","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116163_bib23","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.4155\/fmc-2017-0250","article-title":"Plasmodium falciparum dihydroorotate dehydrogenase: a drug target against malaria","volume":"10","author":"Hoelz","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116163_bib24","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1021\/acsmedchemlett.7b00030","article-title":"Discovery of antimalarial azetidine-2-carbonitriles that inhibit P. Falciparum dihydroorotate dehydrogenase","volume":"8","author":"Maetani","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116163_bib25","first-page":"1864","article-title":"ThermoFMN - a thermofluor assay developed for ligand-screening as an alternative strategy for drug discovery","volume":"25","author":"P\u00e1dua","year":"2014","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116163_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa6645","article-title":"A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria","volume":"7","author":"Phillips","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2024.116163_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00011-19","article-title":"8-Aminoquinoline therapy for latent malaria","volume":"32","author":"Baird","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2024.116163_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1473-3099(13)70268-8","article-title":"Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial","volume":"14","author":"Eziefula","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116163_bib29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ebiom.2016.10.032","article-title":"The gametocytocidal efficacy of different single doses of primaquine with dihydroartemisinin-piperaquine in asymptomatic parasite carriers in the Gambia: a randomized controlled trial","volume":"13","author":"Okebe","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejmech.2024.116163_bib30","doi-asserted-by":"crossref","first-page":"E1214","DOI":"10.1073\/pnas.1112037108","article-title":"Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue","volume":"108","author":"Adjalley","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2024.116163_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.parepi.2023.e00292","article-title":"Prevalence of Plasmodium falciparum gametocytaemia in asymptomatic school children before and after treatment with dihydroartemisinin-piperaquine (DP)","volume":"21","author":"Dinko","year":"2023","journal-title":"Parasite Epidemiol. Control"},{"key":"10.1016\/j.ejmech.2024.116163_bib32","doi-asserted-by":"crossref","first-page":"7650","DOI":"10.1128\/AAC.01948-15","article-title":"In vitro activities of primaquine-schizonticide combinations on asexual blood stages and gametocytes of Plasmodium falciparum","volume":"59","author":"Cabrera","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116163_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12936-015-0586-6","article-title":"Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine","volume":"14","author":"Pascual","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2024.116163_bib34","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1128\/AAC.01793-10","article-title":"Piperaquine resistance is associated with a copy number variation on chromosome 5 in drug-pressured Plasmodium falciparum parasites, Antimicrob","volume":"55","author":"Eastman","year":"2011","journal-title":"Agents Chemother"},{"key":"10.1016\/j.ejmech.2024.116163_bib35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1359-6446(00)01540-3","article-title":"ADME\/PK as part of a rational approach to drug discovery","volume":"5","author":"Eddershaw","year":"2000","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2024.116163_bib36","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2174\/1568026033452096","article-title":"The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery","volume":"3","author":"Lin","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116163_bib37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.drudis.2009.09.010","article-title":"Computational toxicology-a tool for early safety evaluation","volume":"15","author":"Merlot","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2024.116163_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116163_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2024.116163_bib40","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of Pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116163_bib41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cmdc.200700139","article-title":"Lessons learnt from assembling screening libraries for drug discovery for neglected diseases","volume":"3","author":"Brenk","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116163_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/expr.1993.1010","article-title":"Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria","volume":"76","author":"ter Kuile","year":"1993","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2024.116163_bib43","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.116163_bib44","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ejmech.2024.116163_bib45","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening","volume":"48","author":"Smilkstein","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116163_bib46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cellular growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability","volume":"89","author":"Denizot","year":"1986","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejmech.2024.116163_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12936-018-2281-x","article-title":"New endoperoxides highly active in vivo and in vitro against artemisinin-resistant Plasmodium falciparum","volume":"17","author":"Lobo","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2024.116163_bib48","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3389\/fchem.2019.00901","article-title":"Optimal 10-aminoartemisinins with potent transmission-blocking capabilities for new artemisinin combination therapies-activities against blood stage P. Falciparum including PfKI3 C580Y mutants and liver stage P. Berghei parasites","volume":"7","author":"Wong","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2024.116163_bib49","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.ijpara.2012.08.009","article-title":"A high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines","volume":"42","author":"Delves","year":"2012","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejmech.2024.116163_bib50","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3390\/biom10081136","article-title":"Heparin administered to Anopheles in membrane feeding assays blocks Plasmodium development in the mosquito","volume":"10","author":"Lantero","year":"2020","journal-title":"Biomolecules"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424000436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424000436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T19:17:37Z","timestamp":1735067857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424000436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":49,"alternative-id":["S0223523424000436"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116163","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of new piperaquine hybrid analogs linked by triazolopyrimidine and pyrazolopyrimidine scaffolds with antiplasmodial and transmission blocking activities","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116163"}}